HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nucleosides Associated With Incident Ischemic Stroke in the REGARDS and JHS Cohorts.

AbstractBACKGROUND AND OBJECTIVES:
Both genetic and environmental factors contribute to stroke risk. We sought to identify novel metabolites associated with incident stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort and determine whether they reflected genetic or environmental variation.
METHODS:
This was a stroke case-cohort observational study nested in REGARDS. Cases were defined as incident stroke and metabolomic profiles were compared to a randomly selected control cohort. In baseline plasma samples, 162 metabolites were measured using liquid chromatography-tandem mass spectrometry. Cox proportional hazards models were adjusted for age, sex, race, and age by race in the base model. Fully adjusted models included traditional stroke risk factors. Mediation analyses conducted for these stroke risk factors used the metabolite as mediator. Genome-wide associations with the leading candidate metabolites were calculated using array data. Replication analyses in the Jackson Heart Study (JHS) were conducted using random effects meta-analysis.
RESULTS:
There were 2,043 participants who were followed over an average period of 7.1 years, including 1,075 stroke cases and 968 random controls. Nine metabolites were associated with stroke in the base model, 8 of which were measured and remained significant in meta-analysis with JHS. In the fully adjusted model in REGARDS, guanosine (hazard ratio [HR] 1.34, 95% CI 1.18-1.53; p = 7.26 × 10-6) and pseudouridine (HR 1.28, 95% CI 1.13-1.45; p = 1.03 × 10-4) were associated with incident ischemic stroke following Bonferroni adjustment. Guanosine also partially mediated the relationship between hypertension and stroke (17.6%) and pseudouridine did not mediate any risk factor. Genome-wide association analysis identified loci rs34631560 and rs34631560 associated with pseudouridine, but these did not explain the association of pseudouridine with stroke.
DISCUSSION:
Guanosine and pseudouridine are nucleosides associated with incident ischemic stroke independently of other risk factors. Genetic and mediation analyses suggest that environmental exposures rather than genetic variation link nucleoside levels to stroke risk.
CLASSIFICATION OF EVIDENCE:
This study provides Class II evidence that guanosine and pseudouridine are associated with incident stroke.
AuthorsZsuzsanna Ament, Amit Patki, Ninad Chaudhary, Varun M Bhave, Ana-Lucia Garcia Guarniz, Yan Gao, Robert E Gerszten, Adolfo Correa, Suzanne E Judd, Mary Cushman, D Leann Long, M Ryan Irvin, W Taylor Kimberly
JournalNeurology (Neurology) Vol. 98 Issue 21 Pg. e2097-e2107 (05 24 2022) ISSN: 1526-632X [Electronic] United States
PMID35264422 (Publication Type: Journal Article, Observational Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2022 American Academy of Neurology.
Chemical References
  • Nucleosides
  • Guanosine
  • Pseudouridine
Topics
  • Case-Control Studies
  • Coronary Disease
  • Genome-Wide Association Study
  • Guanosine
  • Humans
  • Incidence
  • Ischemic Stroke
  • Longitudinal Studies
  • Nucleosides
  • Pseudouridine
  • Risk Factors
  • Stroke (epidemiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: